Format

Send to

Choose Destination
Rev Med Inst Mex Seguro Soc. 2015;53 Suppl 1:S24-9.

[Maternal and fetal outcome in Mexican women with rheumatoid arthritis].

[Article in Spanish; Abstract available in Spanish from the publisher]

Author information

1
Departamento de Reumatología, Hospital de Especialidades, Centro Médico Nacional La Raza, Instituto Mexicano del Seguro Social, Distrito Federal. miansaavsa@gmail.com.

Abstract

in English, Spanish

OBJECTIVE:

To report our experience in maternal-fetal outcome in women with RA in a national medical referral center.

METHODS:

A retrospective analysis of the records of pregnant women with rheumatoid arthritis attending at a Pregnancy and Autoimmune Rheumatic Diseases Clinic was performed. Maternal-fetal outcomes such as disease activity, preclampsia/eclampsia, rate of live births, abortions, stillbirths, preterm birth, weeks of gestation, birth weight, congenital malformations and use of anti-rheumatic drugs were studied.

RESULTS:

We included 73 pregnancies in 72 patients. Disease activity was documented in 47.2% of patients during pregnancy and/or postpartum and 87.7% of patients received some antirheumatic drug. Preclampsia developed in 8.2% of cases. The live birth rate was 98.6%, with preterm delivery in 15.9% and low weight at term in 17.6% of cases. Cesarean section was performed in 77.1% of cases. The disease activity was not associated with a higher percentage of maternal-fetal complications.

CONCLUSIONS:

Our study showed that most patients do not experience significant activity of RA during pregnancy, fetal outcome is satisfactory and disease activity did not appear to influence significantly the obstetric outcome.

KEYWORDS:

Preclampsia; Pregnancy; Rheumatoid arthritis

PMID:
26020659
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center